Literature DB >> 7059434

The gut wall metabolism of ethinyloestradiol and its contribution to the pre-systemic metabolism of ethinyloestradiol in humans.

D J Back, A M Breckenridge, M MacIver, M Orme, H S Purba, P H Rowe, I Taylor.   

Abstract

1 Five patients have been studied to determine the contribution of the gut wall to the pre-systemic metabolism of ethinyloestradiol. All patients had a catheter inserted into their hepatic portal vein as part of their surgical management. 2 After an oral dose of 50 micrograms (65 microCi) ethinyloestradiol, blood samples were taken from the hepatic portal vein and from a peripheral vein at intervals for 1 h. 3 In each patient the concentration of conjugated ethinyloestradiol in the portal vein was considerably higher than in the peripheral vein. 4 Although a number of assumptions have been made, calculations showed that the gut wall appeared to be twice as effective as the liver in conjugating ethinyloestradiol on the first pass. 5 In two patients there was no evidence of major uptake or metabolism of ethinyloestradiol in the lung.

Entities:  

Keywords:  Biology; Case Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Ethinyl Estradiol; Family Planning; Literature Review; Metabolic Effects; Physiology; Research Methodology; Steroid Metabolic Effects; Studies

Mesh:

Substances:

Year:  1982        PMID: 7059434      PMCID: PMC1402099          DOI: 10.1111/j.1365-2125.1982.tb01382.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Formation of oestrone glucosiduronate by the human intestinal tract.

Authors:  E DICZFALUSY; C FRANKSSON; B P LISBOA; B MARTINSEN
Journal:  Acta Endocrinol (Copenh)       Date:  1962-08

2.  Oestrogen conjugation by the human intestinal tract.

Authors:  E DICZFALUSY; C FRANKSSON; B MARTINSEN
Journal:  Acta Endocrinol (Copenh)       Date:  1961-09

Review 3.  Presystemic drug elimination.

Authors:  P A Routledge; D G Shand
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

4.  Pharmacokinetics of salicylamide elimination in man.

Authors:  G Levy; T Matsuzawa
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

5.  Proscillaridin activity in portal and peripheral venous blood after oral administration to man.

Authors:  K E Andersson; B Bergdahl; H Dencker; G Wettrell
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

6.  Metabolism of flurazepam by the small intestine.

Authors:  W A Mahon; T Inaba; R M Stone
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

7.  The in vitro metabolism of ethinyloestradiol, mestranol and levonorgestrel by human jejunal mucosa.

Authors:  D J Back; M Bates; A M Breckenridge; A Ellis; J M Hall; M Maciver; M L Orme; P H Rowe
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

8.  An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay.

Authors:  D J Back; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe; M J Watts
Journal:  Contraception       Date:  1979-09       Impact factor: 3.375

  8 in total
  18 in total

Review 1.  Progress in clinical pharmacology over the last 20 years.

Authors:  Michel Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 3.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 4.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

Review 5.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

6.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.

Authors:  J Säwe; L Kager; J O Svensson Eng; A Rane
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

Review 7.  The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.

Authors:  M L Orme
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

Review 8.  Oral Contraceptives after Bariatric Surgery.

Authors:  Joël Schlatter
Journal:  Obes Facts       Date:  2017-04-22       Impact factor: 3.942

9.  Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.

Authors:  Emma Andrews; Bharat D Damle; Annie Fang; Grover Foster; Penelope Crownover; Robert LaBadie; Paul Glue
Journal:  Br J Clin Pharmacol       Date:  2008-02-21       Impact factor: 4.335

Review 10.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.